Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Cancer charity sees success re-prioritizing industry's shelved compounds

Subjects

Cancer Research UK launched a bold scheme in 2006 to give second chances to industry's de-prioritized compounds. Its first two projects have now run their course, with varying degrees of success.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Authors

PowerPoint slides

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Mullard, A. Cancer charity sees success re-prioritizing industry's shelved compounds. Nat Rev Drug Discov 13, 319–321 (2014). https://doi.org/10.1038/nrd4315

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd4315

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing